FDA Approves New Animal Drug for Swine Infections

Summary

The FDA is updating its regulations to reflect the approval of a new animal drug application for lincomycin, a treatment for swine infections, filed by Phoenix Scientific, Inc. The new approval allows for the use of lincomycin injectable solution to treat infectious arthritis and mycoplasma pneumonia in swine.